Sign in

CIK 0001427925

  • Non-accelerated filer
  • Smaller reporting company

TALPHERA, INC.

Sign in to watch
Ticker
TLPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
412193603
Phone
+1 650-216-3500
Business address
1850 GATEWAY DRIVE, SUITE 175, SAN MATEO, CA, 94404
Former names
ACELRX PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-12-14 Angotti Vincent J. Chief Executive Officer Purchase +3,610 $2.78 $10K 54,650
2018-12-14 ASADORIAN RAFFI Chief Financial Officer Purchase +5,000 $2.78 $14K 52,000
2018-12-12 Angotti Vincent J. Chief Executive Officer Purchase +10,000 $2.99 $30K 51,040
2018-11-19 Palmer Pamela P Chief Medical Officer Purchase +16,000 $3.07 $49K 472,134
2018-11-15 EDWARDS MARK G Director Purchase +20,700 $2.82 $58K 181,000
2018-11-13 ASADORIAN RAFFI Chief Financial Officer Purchase +5,000 $3.13 $16K 47,000
2018-11-02 Hamel Lawrence G Chief Development Officer Grant or award +5,000 $2.23 $11K 34,795
2018-11-02 Hamel Lawrence G Chief Development Officer Returned to the company −5,000 $5.00 $25K 29,795
2018-11-02 Hamel Lawrence G Chief Development Officer Grant or award · Stock Option (Right to Buy) +26,125 26,125
2018-11-02 Hamel Lawrence G Chief Development Officer Returned to the company · Stock Option (Right to Buy) −5,000 21,125
2018-11-02 Dasu Badri N Chief Engineering Officer Grant or award · Stock Option (Right to Buy) +31,625 31,625
2018-11-02 ASADORIAN RAFFI Chief Financial Officer Grant or award · Stock Option (Right to Buy) +40,562 40,562
2018-11-02 Palmer Pamela P Chief Medical Officer Grant or award · Stock Option (Right to Buy) +47,575 47,575
2018-11-02 Angotti Vincent J. Chief Executive Officer Grant or award · Stock Option (Right to Buy) +96,250 96,250
2018-10-15 Hamel Lawrence G Chief Development Officer Sale −5,216 $5.00 $26K 29,795
2018-10-15 Dasu Badri N Chief Engineering Officer Sale −28,351 $5.00 $142K 54,061
2018-09-24 Hamel Lawrence G Chief Development Officer Sale −6,953 $4.50 $31K 35,011
2018-08-31 Dasu Badri N Chief Engineering Officer Grant or award +8,022 $1.49 $12K 82,412
2018-08-31 ASADORIAN RAFFI Chief Financial Officer Grant or award +10,000 $1.49 $15K 42,000
2018-08-31 Angotti Vincent J. Chief Executive Officer Grant or award +6,040 $1.49 $9K 41,040

Page 16 of 17 · 329 trades